| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8827533 | Transplantation Proceedings | 2017 | 4 Pages |
Abstract
RCVS should always be considered as a cause of headache in heart transplant recipients because tacrolimus, an immunosuppressive agent, may trigger RCVS. This will allow rapid intervention that is essential for avoiding irreversible neurological deficits.
Related Topics
Health Sciences
Medicine and Dentistry
Surgery
Authors
Y. Kumai, O. Seguchi, T. Sato, K. Wada, M. Shiozawa, C. Yokota, K. Kuroda, S. Nakajima, T. Sato, M. Yanase, Y. Matsumoto, S. Fukushima, T. Fujita, J. Kobayashi, N. Fukushima,